Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- QLGN
- Price
- 3.00
- Stock movement down
- -0.05 (-1.64%)
- Company name
- Qualigen Therapeutics Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 2.21M
- Ent value
- 6.27M
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -0.90%
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -68.35%
- 1 year return
- -84.21%
- 3 year return
- -78.64%
- 5 year return
- -75.02%
- 10 year return
- -
Last updated: 2025-04-12
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
QLGN does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 736.43K |
| EPS (TTM) | -20.29 |
| FCF per share (TTM) | -25.08 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | -1.12M |
| Operating income (TTM) | -6.70M |
| Net income (TTM) | -7.87M |
| EPS (TTM) | -20.29 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 388.15K |
| Net receivables | 1.30M |
| Total current assets | 2.31M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 2.31M |
| Accounts payable | 1.64M |
| Short/Current long term debt | 1.43M |
| Total current liabilities | 4.45M |
| Total liabilities | 4.45M |
| Shareholder's equity | -2.14M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -9.73M |
| Capital expenditures (TTM) | 4.00 |
| Free cash flow (TTM) | -9.73M |
| Dividends paid (TTM) | 87.60K |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | -340.29% |
| Return on Invested Capital | 1113.88% |
| Cash Return on Invested Capital | 1376.92% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 3.05 |
| Daily high | 3.30 |
| Daily low | 2.85 |
| Daily Volume | 25K |
| All-time high | 597500.00 |
| 1y analyst estimate | 5.00 |
| Beta | 0.14 |
| EPS (TTM) | -20.29 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | 30 Jun 2025 |
Downside potential
Loading...
Downside potential data
| QLGN | S&P500 | |
| Current price drop from All-time high | -100.00% | -12.89% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 11 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -90.03% | -11.07% |
| Avg time to new high | 2466 days | 12 days |
| Max time to new high | 2465 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
2.21M
Marketcap category
Small-cap
Description
Qualigen Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of treatments for adult and pediatric cancer in the United States. The company's lead program is QN-302, an investigational small molecule G-quadruplexes (G4)-selective transcription inhibitor, which is in Phase 1a clinical trial for the treatment of pancreatic cancer and other solid tumors. It is also developing Pan-RAS that is in preclinical stage for the treatment of advanced solid tumors. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.
Employees
4
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page